Edenbridge Pharmaceuticals recalls
Edenbridge Pharmaceuticals has 1 recall on record with the FDA and USDA, the earliest in 2023 and the latest reported on 8 Nov 2023. The most frequent reason is potency & assay.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 8 Nov 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why edenbridge pharmaceuticals is recalled
Product types
By year
All edenbridge pharmaceuticals recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine recalledOpium Tincture Deodorized | Edenbridge Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.